{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:21:32Z","timestamp":1792167692484,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19591190"],"award-info":[{"award-number":["19591190"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21591304"],"award-info":[{"award-number":["21591304"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","award":["13-401"],"award-info":[{"award-number":["13-401"]}],"id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","award":["14-402"],"award-info":[{"award-number":["14-402"]}],"id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","award":["15-405A"],"award-info":[{"award-number":["15-405A"]}],"id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","award":["16-405M"],"award-info":[{"award-number":["16-405M"]}],"id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","award":["17-402M"],"award-info":[{"award-number":["17-402M"]}],"id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","award":["18-401"],"award-info":[{"award-number":["18-401"]}],"id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","award":["19-402M"],"award-info":[{"award-number":["19-402M"]}],"id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","award":["20-4030"],"award-info":[{"award-number":["20-4030"]}],"id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.resinv.2021.09.009","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T20:16:01Z","timestamp":1636143361000},"page":"56-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Atypical pneumonia: Pathophysiology, diagnosis, and treatment"],"prefix":"10.1016","volume":"60","author":[{"given":"Naoyuki","family":"Miyashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2021.09.009_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/eurheartj\/19.6.971","article-title":"An association of an antibody against Chlamydia pneumoniae and coronary heart disease observed in Japan","volume":"19","author":"Miyashita","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.resinv.2021.09.009_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2169\/internalmedicine.37.913","article-title":"Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japan","volume":"37","author":"Miyashita","year":"1998","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1348-0421.2000.tb02564.x","article-title":"Seroprevalence of antibodies to Chlamydia spp. in human immunodeficiency virus-infected subjects in Japan","volume":"44","author":"Miyashita","year":"2000","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.resinv.2021.09.009_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/1352458502ms840oa","article-title":"Chlamydia pneumoniae infection associated with enhanced MRI-spinal lesions in multiple sclerosis","volume":"8","author":"Hao","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.resinv.2021.09.009_bib5","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ejim.2015.11.011","article-title":"Extra-pulmonary manifestations associated with Mycoplasma pneumoniae pneumonia in adults","volume":"29","author":"Kawai","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001432-200204000-00010","article-title":"Etiology and management of community-acquired pneumonia in Asia","volume":"15","author":"Matsushima","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10156-005-0425-8","article-title":"Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan","volume":"12","author":"Saito","year":"2006","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1378\/chest.119.4.1295-a","article-title":"Etiology of community-acquired pneumonia requiring hospitalization in Japan","volume":"119","author":"Miyashita","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2021.09.009_bib9","first-page":"67","article-title":"Q fever in acute respiratory infection","volume":"42","author":"Okimoto","year":"2016","journal-title":"Kawasaki Med J"},{"key":"10.1016\/j.resinv.2021.09.009_bib10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1378\/chest.117.2.615","article-title":"Community-acquired Chlamydia pneumoniae pneumonia","volume":"117","author":"Miyashita","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2021.09.009_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1099\/0022-1317-49-4-391","article-title":"Chlamydia pneumoniae infection during an influenza virus A epidemic: preliminary report","volume":"49","author":"Miyashita","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib13","first-page":"S79","article-title":"The Japanese respiratory society guidelines for the management of community-acquired pneumonia in adults","volume":"11 S-3","author":"Matsushima","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1099\/jmm.0.46191-0","article-title":"Outbreak of Chlamydia pneumoniae infection in long-term care facilities and an affiliated hospital","volume":"54","author":"Miyashita","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2169\/internalmedicine.51.6475","article-title":"Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between teaching university hospital and community hospital","volume":"51","author":"Miyashita","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10156-012-0491-7","article-title":"Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia","volume":"19","author":"Miyashita","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib17","first-page":"S1","article-title":"The Japanese respiratory society guidelines for the management of hospital-acquired pneumonia in adults","volume":"14 S-2","author":"Kohno","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1099\/jmm.0.45920-0","article-title":"Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study","volume":"54","author":"Miyashita","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jcp.55.2.115","article-title":"Seroepidemiology of Chlamydia pneumoniae in Japan between 1991 and 2000","volume":"55","author":"Miyashita","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.resinv.2021.09.009_bib20","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1378\/chest.119.5.1416","article-title":"Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults","volume":"119","author":"Miyashita","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2021.09.009_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2169\/internalmedicine.41.30","article-title":"Recurrent pneumonia due to persistent Chlamydia pneumoniae infection","volume":"41","author":"Miyashita","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.pupt.2009.08.004","article-title":"Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells","volume":"22","author":"Morinaga","year":"2009","journal-title":"Pulm Pharmacol Therapeut"},{"key":"10.1016\/j.resinv.2021.09.009_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1081-1206(10)62992-4","article-title":"Chlamydia pneumoniae and exacerbations of asthma in adults","volume":"80","author":"Miyashita","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.resinv.2021.09.009_bib24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1378\/chest.114.4.969","article-title":"Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD","volume":"114","author":"Miyashita","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2021.09.009_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1348-0421.1996.tb01107.x","article-title":"Continuous isolation and characterization of Chlamydia pneumoniae from a patient with diffuse panbronchiolitis","volume":"40","author":"Miyashita","year":"1996","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.resinv.2021.09.009_bib26","first-page":"103","article-title":"Chlamydia pneumoniae and asthma. Recent research developments in allergy","author":"Miyashita","year":"2001","journal-title":"Asthma & Immunology"},{"key":"10.1016\/j.resinv.2021.09.009_bib27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1099\/00222615-38-6-418","article-title":"The morphology of Chlamydia pneumonaie","volume":"38","author":"Miyashita","year":"1993","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib28","first-page":"255","article-title":"Morphological analysis of Chlamydia pneumoniae","volume":"45","author":"Miyashita","year":"1997","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib29","series-title":"Chlamydia pneumoniae infection and disease","first-page":"11","article-title":"Morphology of Chlamydia pneumoniae","author":"Miyashita","year":"2004"},{"key":"10.1016\/j.resinv.2021.09.009_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/jcm.32.3.583-588.1994","article-title":"Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans","volume":"32","author":"Iijima","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib31","first-page":"1","article-title":"Microbiology of Chlamydiae\uff0dwith emphasis on physicochemistry, antigenicity and drug susceptibility of Chlamydia pneumonaie\uff0d","volume":"20","author":"Miyashita","year":"1994","journal-title":"Kawasaki Med J"},{"key":"10.1016\/j.resinv.2021.09.009_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1348-0421.1994.tb02138.x","article-title":"Characterization of a Chlamydia pneumoniae strain isolated from a 57-year-old man","volume":"38","author":"Miyashita","year":"1994","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.resinv.2021.09.009_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1348-0421.1993.tb03241.x","article-title":"Antigenic characterization of Chlamydia pneumoniae isolated in Hiroshima, Japan","volume":"37","author":"Kanamoto","year":"1993","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.resinv.2021.09.009_bib34","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1128\/JCM.36.10.3013-3019.1998","article-title":"Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma","volume":"36","author":"Matsumoto","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib35","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2169\/internalmedicine.44.870","article-title":"Self-limiting pneumonia due to Chlamydia pneumoniae","volume":"44","author":"Miyashita","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib36","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1099\/jmm.0.47119-0","article-title":"Clinical features of severe Mycoplasma pneumoniae in adults admitted to an intensive care unit","volume":"56","author":"Miyashita","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib37","doi-asserted-by":"crossref","first-page":"m3862","DOI":"10.1136\/bmj.m3862","article-title":"Virology, transmission, and pathogenesis of SARS-CoV-2","volume":"371","author":"Cevik","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2021.09.009_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1099\/jmm.0.04986-0","article-title":"Chlamydia pneumoniae infection in adult patients with persistent cough","volume":"52","author":"Miyashita","year":"2003","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib39","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2169\/internalmedicine.50.4768","article-title":"Outbreak of pertussis in a university laboratory","volume":"50","author":"Miyashita","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib40","first-page":"129","article-title":"Q fever in adult patients with prolonged cough","volume":"37","author":"Okimoto","year":"2011","journal-title":"Kawasaki Med J"},{"key":"10.1016\/j.resinv.2021.09.009_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2334-13-129","article-title":"Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients","volume":"13","author":"Miyashita","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1440-1843.2011.02024.x","article-title":"Evaluation of serological tests for diagnosis of Bordetella pertussis infection in adolescents and adults","volume":"16","author":"Miyashita","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib43","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1378\/chest.121.6.1776","article-title":"Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults","volume":"121","author":"Miyashita","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2021.09.009_bib44","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2169\/internalmedicine.41.943","article-title":"Community-acquired Chlamydia pneumoniae pneumonia in Japan: a prospective multicenter community-acquired pneumonia study","volume":"41","author":"Miyashita","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1440-1843.2012.02188.x","article-title":"Influence of age in the clinical differentiation of atypical pneumonia in adults","volume":"17","author":"Miyashita","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib46","first-page":"CR387","article-title":"Mycoplasma pneumoniae pneumonia in the elderly","volume":"14","author":"Miyashita","year":"2008","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"key":"10.1016\/j.resinv.2021.09.009_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jiac.2017.09.001","article-title":"Clinical presentation of Legionella pneumonia: evaluation of clinical scoring systems and therapeutic efficacy","volume":"23","author":"Miyashita","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib48","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1128\/jcm.30.11.2911-2916.1992","article-title":"Establishment of a particle-counting method for purified elementary bodies of Chlamydiae and evaluation of sensitivities of IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies","volume":"30","author":"Miyashita","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.11150\/kansenshogakuzasshi1970.67.549","article-title":"Reactivity of Chlamydia pneumoniae strains in the IDEIA CHLAMYDIA test kit designed for detection of Chlamydia trachomatis","volume":"67","author":"Miyashita","year":"1993","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.resinv.2021.09.009_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1348-0421.1994.tb01747.x","article-title":"Evaluation of the sensitivity and specificity of polymerase chain reaction test kit, AMPLICOR Chlamydia trachomatis","volume":"38","author":"Miyashita","year":"1994","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.resinv.2021.09.009_bib51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jcp.49.6.515","article-title":"Evaluation of the sensitivity and specificity of ligase chain reaction test kit for the detection of Chlamydia trachomatis","volume":"49","author":"Miyashita","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.resinv.2021.09.009_bib52","first-page":"CR171","article-title":"Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization","volume":"14","author":"Miyashita","year":"2008","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"key":"10.1016\/j.resinv.2021.09.009_bib53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.11150\/kansenshogakuzasshi1970.70.224","article-title":"Evaluation of a direct fluorescent antibody assay for detection of Chlamydia pneumoniae","volume":"70","author":"Miyashita","year":"1996","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.resinv.2021.09.009_bib54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000092547","article-title":"Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan","volume":"4","author":"Kobashi","year":"2007","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2021.09.009_bib55","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.rmed.2003.11.012","article-title":"The CAP study group: multiplex PCR for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in community-acquired pneumonia study","volume":"98","author":"Miyashita","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10156-007-0509-8","article-title":"Evaluation of diagnostic usefulness of real-time PCR for detection of Chlamydophila pneumoniae in acute respiratory infections","volume":"13","author":"Miyashita","year":"2007","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib57","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10096-009-0710-z","article-title":"Development and evaluation of a loop-mediated isothermal amplification method for rapid detection of Chlamydophila pneumoniae","volume":"28","author":"Kawai","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jiac.2015.03.003","article-title":"Antibody responses of Chlamydophila pneumoniae pneumonia: why is the diagnosis of C. pneumoniae pneumonia difficult?","volume":"21","author":"Miyashita","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib59","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/CVI.00085-08","article-title":"Rapid and simple diagnosis of Chlamydophila pneumoniae pneumonia by an immunochromatographic test for detection of immunoglobulin M antibodies","volume":"15","author":"Miyashita","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.resinv.2021.09.009_bib60","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2169\/internalmedicine.45.6074","article-title":"Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1440-1843.2007.01230.x","article-title":"Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae","volume":"13","author":"Miyashita","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1440-1843.2007.01196.x","article-title":"Evaluation of enzyme-linked immunosorbent assay for Chlamydophila pneumoniae-specific immunoglobulin M in acute respiratory tract infection","volume":"13","author":"Miyashita","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib63","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10156-012-0494-4","article-title":"The atypical pathogen study group: Chlamydophila pneumoniae serology: cross-reaction with Mycoplasma pneumoniae infection","volume":"19","author":"Miyashita","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7883\/yoken.63.150","article-title":"Evaluation of false-positive reaction with ELISA for the detection of Chlamydophila pneumoniae-specific IgM antibody in adults","volume":"63","author":"Miyashita","year":"2010","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-010-1107-8","article-title":"The Atypical Pathogen Study Group: clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults","volume":"30","author":"Miyashita","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib66","first-page":"61","article-title":"Association between ImmunoCard Mycoplasma and particle agglutination (PA) method in Mycoplasma pneumonia diagnosis","volume":"40","author":"Okimoto","year":"2014","journal-title":"Kawasaki Med J"},{"key":"10.1016\/j.resinv.2021.09.009_bib67","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jiac.2016.02.005","article-title":"Rapid diagnostic method for the identification of Mycoplasma pneumoniae respiratory tract infection","volume":"22","author":"Miyashita","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jiac.2015.02.007","article-title":"Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: comparison with real-time PCR","volume":"21","author":"Miyashita","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2342-9-7","article-title":"Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing","volume":"9","author":"Miyashita","year":"2009","journal-title":"BMC Med Imag"},{"key":"10.1016\/j.resinv.2021.09.009_bib70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/resp.12218","article-title":"Chest computed tomography for the diagnosis of Mycoplasma pneumoniae infection","volume":"19","author":"Miyashita","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib71","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jiac.2015.03.002","article-title":"Detection failure rate of chest radiography for the identification of nursing and healthcare-associated pneumonia","volume":"21","author":"Miyashita","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib72","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1440-1843.2006.00927.x","article-title":"Clinical differentiation of atypical pneumonia using Japanese guidelines","volume":"12","author":"Ishida","year":"2007","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib73","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.rmed.2004.03.011","article-title":"Is it possible to distinguish between atypical pneumonia and bacterial pneumonia?: evaluation of the guidelines for community-acquired pneumonia in Japan","volume":"98","author":"Miyashita","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2021.09.009_bib74","first-page":"122","article-title":"Japanese guidelines for the management of community-acquired pneumonia: is it possible to distinguish between mycoplasmal pneumonia and bacterial pneumonia?","volume":"31","author":"Miyashita","year":"2004","journal-title":"Jpn J Mycoplasmology"},{"key":"10.1016\/j.resinv.2021.09.009_bib75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jiac.2017.12.009","article-title":"Diagnostic predictors of Legionella pneumonia in Japan","volume":"24","author":"Miyashita","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib76","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jiac.2019.03.009","article-title":"Validation of a diagnostic score model for the prediction of Legionella pneumophila pneumonia","volume":"25","author":"Miyashita","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib77","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1128\/AAC.38.10.2296","article-title":"In\u00a0vitro and in\u00a0vivo activities of azithromycin, a new azalide antibiotic, against Chlamydia","volume":"38","author":"Niki","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib78","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jac\/48.3.403","article-title":"In\u00a0vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae","volume":"48","author":"Miyashita","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib79","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jac\/dkg371","article-title":"In\u00a0vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae","volume":"52","author":"Miyashita","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1348-0421.2000.tb02493.x","article-title":"In\u00a0vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains","volume":"44","author":"Miyashita","year":"2000","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.resinv.2021.09.009_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s101560100018","article-title":"The 7.5-kb common plasmid is unrelated to the drug susceptibility of Chlamydia trachomatis","volume":"7","author":"Miyashita","year":"2001","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02348753","article-title":"In\u00a0vitro and in\u00a0vivo activities of sparfloxacin and reference drugs against Chlamydia pneumoniae","volume":"1","author":"Soejima","year":"1995","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib83","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/AAC.41.4.857","article-title":"In\u00a0vitro and in\u00a0vivo antichlamydial activities of HSR-903, a new fluoroquinolone antibiotic","volume":"41","author":"Niki","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib84","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.41.6.1331","article-title":"In\u00a0vitro and in\u00a0vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp","volume":"41","author":"Miyashita","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib85","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1128\/AAC.45.11.3270-3272.2001","article-title":"In\u00a0vitro and in\u00a0vivo activities of sitafloxacin against Chlamydia spp","volume":"45","author":"Miyashita","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s101560200019","article-title":"In\u00a0vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species","volume":"8","author":"Miyashita","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jiac.2018.01.018","article-title":"In\u00a0vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan","volume":"24","author":"Miyashita","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib88","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jiac.2019.12.016","article-title":"Distribution of Legionella species and serogroups in patients with culture-confirmed Legionella pneumonia","volume":"26","author":"Miyashita","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib89","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jiac.2014.05.002","article-title":"Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: postmarketing surveillance in Japan","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib90","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jiac.2014.05.003","article-title":"Efficacy and safety of garenoxacin tablets on clinically diagnosed bacterial pneumonia: postmarketing surveillance in Japan","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib91","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1128\/AAC.00663-13","article-title":"Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib92","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijantimicag.2010.06.009","article-title":"The atypical pathogen study group: macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia","volume":"36","author":"Miyashita","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.resinv.2021.09.009_bib93","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10156-010-0093-1","article-title":"Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients with over 18 years","volume":"17","author":"Miyashita","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib94","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2334-12-126","article-title":"The atypical pathogen study group: macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia","volume":"12","author":"Miyashita","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib95","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s10156-013-0604-y","article-title":"Transmission of macrolide-resistant Mycoplasma pneumoniae within a family","volume":"19","author":"Miyashita","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib96","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7883\/yoken.65.535","article-title":"The Atypical Pathogen Study Group: in\u00a0vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates in pediatric patients: results from multicenter surveillance","volume":"65","author":"Akaike","year":"2012","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1843.2011.02102.x","article-title":"Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"17","author":"Kawai","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib98","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib99","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/AAC.00737-13","article-title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility and therapeutic efficacy","volume":"57","author":"Miyashita","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10156-013-0575-z","article-title":"Atelectasis caused by macrolide-resistant Mycoplasma pneumoniae pneumonia in an adult patient","volume":"19","author":"Miyashita","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib101","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1099\/jmm.0.000501","article-title":"Histologic findings in severe Mycoplasma pneumoniae pneumonia","volume":"66","author":"Miyashita","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2021.09.009_bib102","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jiac.2014.01.001","article-title":"Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level","volume":"20","author":"Inamura","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib103","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jiac.2014.10.008","article-title":"Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults","volume":"21","author":"Miyashita","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2021.09.009_bib104","doi-asserted-by":"crossref","first-page":"14061","DOI":"10.1038\/srep14061","article-title":"Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-Analysis 2015 Update","volume":"5","author":"Horita","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2021.09.009_bib105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jgs.13986","article-title":"Macrolide therapy for prevention of exacerbation in patients with diffuse aspiration bronchiolitis","volume":"64","author":"Miyashita","year":"2016","journal-title":"J Am Geriatir Soc"},{"key":"10.1016\/j.resinv.2021.09.009_bib106","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/resp.12835","article-title":"Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: systematic review and meta-analysis","volume":"21","author":"Horita","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2021.09.009_bib107","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/cid\/cit571","article-title":"A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter- cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy","volume":"57","author":"Maruyama","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib108","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/ciy631","article-title":"A Therapeutic Strategy for All Pneumonia Patients: a 3-Year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy","volume":"68","author":"Maruyama","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2021.09.009_bib109","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1080\/21645515.2019.1584023","article-title":"The Study Group for Pneumonia in the Elderly Individuals. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study","volume":"15","author":"Suzuki","year":"2019","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.resinv.2021.09.009_bib110","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/s41598-021-84348-w","article-title":"The Pneumonia in the Elderly People Study Group. Association between coffee and green tea intake and pneumonia among the Japanese elderly: a case-control study","volume":"11","author":"Kondo","year":"2021","journal-title":"Sci Rep"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534521001775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534521001775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:32:09Z","timestamp":1761949929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534521001775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2212534521001775"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2021.09.009","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical pneumonia: Pathophysiology, diagnosis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}